Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

European Registry of Consecutive Patients Undergoing PCI Evaluating the Use of the Thrombin-specific Anticoagulant Bivalirudin With Focus on Patient Selection, Convenience and Safety Aspects.

NCT00290849 is registered in ClinicalTrials.gov with Nycomed as lead sponsor.

NCT NCT00290849
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00290849 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
European Registry of Consecutive Patients Undergoing PCI Evaluating the Use of the Thrombin-specific Anticoagulant Bivalirudin With Focus on Patient Selection, Convenience and Safety Aspects.
Lead sponsor
Nycomed
Phase
Observational
Overall status
Completed
Start date
March 31, 2005
Completion date
September 30, 2007
Enrollment
4,000
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

thrombin-specific anticoagulant bivalirudin during percutaneous coronary intervention (pci)